ad image

Influenza

1 / 2
Osivax

Osivax Receives Over EUR 30M in Public Funding to Support Development of Universal Coronavirus and Influenza Vaccines

Osivax

PR-M07-20-NI-010Jul 09, 2020
Applying the Principles of Immunotherapy to Infectious Diseases
Immunotherapy

Applying the Principles of Immunotherapy to Infectious Diseases

Jeffrey Stein, Ph.D.

Cidara Therapeutics

PAP-Q2-20-CL-018Jul 01, 2020
Marinova
H1N1

Seaweed Extract Reduces Flu Severity

Marinova

PR-M05-20-NI-018-1563May 12, 2020
Davidson Institute
Influenza

Bloomfield Hills Teen Awarded $25,000 for Developing Method to Create Universal Influenza Vaccine

Davidson Institute

PR-M08-19-NI-060Aug 21, 2019
Sanofi
Influenza

Sanofi Signs Strategic Deal for Exclusive US Over-the-Counter Rights to Tamiflu® in Flu Care

Sanofi

PR-M07-19-NI-061Jul 24, 2019
Genentech’s Xofluza Flu Treatment Effective in Children
Influenza

Genentech’s Xofluza Flu Treatment Effective in Children

Emilie Branch

Pharma's Almanac

PAO-M07-19-NI-019Jul 22, 2019
GSK Ships 2019-20 Seasonal Influenza Vaccines for US Market
Influenza

GSK Ships 2019-20 Seasonal Influenza Vaccines for US Market

Nice Insight

PR-M07-19-NI-047-2363Jul 19, 2019
Moderna
Vaccines

Moderna Announces Publication of Phase 1 Data for mRNA Vaccines Against Two Potential Pandemic Influenza Strains

Moderna

PR-M05-19-NI-041May 14, 2019
Genentech Receives FDA Approval for Flu Medicine
FDA Approval

Genentech Receives FDA Approval for Flu Medicine

David Alvaro, Ph.D.

Pharma's Almanac

PAO-M11-18-NI-001Nov 05, 2018
Abbott
Influenza

Abbott Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results

Abbott

PR-M10-18-NI-099Oct 29, 2018
Cell-Based Flu Vaccines Appear to Be More Effective than Egg-Based Strains
Influenza

Cell-Based Flu Vaccines Appear to Be More Effective than Egg-Based Strains

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M10-18-NI-017Oct 22, 2018
FluMist Shipped by AstraZeneca
Influenza

FluMist Shipped by AstraZeneca

Nice Insight

PAO-M10-18-NI-007-3592Oct 04, 2018
BioNTech
Collaboration

BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza

BioNTech

PR-M09-18-NI-052Sep 18, 2018
GSK Contract Manufacturing
Vaccines

GSK Ships 2018-19 Seasonal Influenza Vaccines for US Market

GSK Contract Manufacturing

PR-M08-18-NI-110Aug 29, 2018
Brexit Issues Could Impact Flu Shot Deliveries to the UK
Influenza

Brexit Issues Could Impact Flu Shot Deliveries to the UK

Nice Insight

PAO-M08-18-NI-022Aug 22, 2018
Anti-Flu Drug Exploits Weakness in H3N2 Strain
Influenza

Anti-Flu Drug Exploits Weakness in H3N2 Strain

Emilie Branch

Pharma's Almanac

PAO-M03-18-NI-021Mar 23, 2018
New BI Vaccine Allows Very Early Vaccination of Piglets Against Swine Flu
Influenza

New BI Vaccine Allows Very Early Vaccination of Piglets Against Swine Flu

Nigel Walker

Nice Insight

PAO-M03-18-NI-010Mar 09, 2018
GSK
Influenza

GSK presents new efficacy data for FLUARIX® QUADRIVALENT (Influenza Vaccine) in children 6 months through 35 months of age

GSK

PR-M02-18-NI-87Feb 23, 2018
GlaxoSmithKline
Vaccine

GSK receives FDA approval for expanded indication for FLUARIX® QUADRIVALENT (Influenza Vaccine) for persons 6 months and older

GlaxoSmithKline

PR-M01-18-NI-046Jan 17, 2018
Sanofi Expanding Manufacturing Capacity for Quadrivalent Influenza Vaccine
Capacity Expansion

Sanofi Expanding Manufacturing Capacity for Quadrivalent Influenza Vaccine

Guy Tiene

Nice Insight

PAO-M10-17-NI-043Oct 26, 2017
1 / 2